Changes in the Expression of Human Cell Division Autoantigen-1 Influence Toxoplasma gondii Growth and Development

Toxoplasma is a significant opportunistic pathogen in AIDS, and bradyzoite differentiation is the critical step in the pathogenesis of chronic infection. Bradyzoite development has an apparent tropism for cells and tissues of the central nervous system, suggesting the need for a specific molecular environment in the host cell, but it is unknown whether this environment is parasite directed or the result of molecular features specific to the host cell itself. We have determined that a trisubstituted pyrrole acts directly on human and murine host cells to slow tachyzoite replication and induce bradyzoite-specific gene expression in type II and III strain parasites but not type I strains. New mRNA synthesis in the host cell was required and indicates that novel host transcripts encode signals that were able to induce parasite development. We have applied multivariate microarray analyses to identify and correlate host gene expression with specific parasite phenotypes. Human cell division autoantigen-1 (CDA1) was identified in this analysis, and small interfering RNA knockdown of this gene demonstrated that CDA1 expression causes the inhibition of parasite replication that leads subsequently to the induction of bradyzoite differentiation. Overexpression of CDA1 alone was able to slow parasite growth and induce the expression of bradyzoite-specific proteins, and thus these results demonstrate that changes in host cell transcription can directly influence the molecular environment to enable bradyzoite development. Investigation of host biochemical pathways with respect to variation in strain type response will help provide an understanding of the link(s) between the molecular environment in the host cell and parasite development.

[1]  I. Coppens,et al.  The host cell transcription factor hypoxia‐inducible factor 1 is required for Toxoplasma gondii growth and survival at physiological oxygen levels , 2006, Cellular microbiology.

[2]  Aaron J Mackey,et al.  The transcriptome of Toxoplasma gondii , 2005, BMC Biology.

[3]  J. Boothroyd,et al.  Differences among the three major strains of Toxoplasma gondii and their specific interactions with the infected host. , 2005, Trends in parasitology.

[4]  C. Dominguez,et al.  p38 MAP kinase inhibitors: many are made, but few are chosen. , 2005, Current opinion in drug discovery & development.

[5]  A. Sinai,et al.  Detection of a novel parasite kinase activity at the Toxoplasma gondii parasitophorous vacuole membrane capable of phosphorylating host IκBα , 2005, Cellular microbiology.

[6]  B. Striepen,et al.  Identification of a sporozoite‐specific member of the Toxoplasma SAG superfamily via genetic complementation , 2004, Molecular microbiology.

[7]  A. Sinai,et al.  Mechanisms underlying the manipulation of host apoptotic pathways by Toxoplasma gondii. , 2004, International journal for parasitology.

[8]  L. Sibley,et al.  A role for coccidian cGMP-dependent protein kinase in motility and invasion. , 2004, International journal for parasitology.

[9]  A. Sinai,et al.  Inhibition of caspase activation and a requirement for NF-κB function in the Toxoplasma gondii-mediated blockade of host apoptosis , 2003, Journal of Cell Science.

[10]  M. White,et al.  A change in the premitotic period of the cell cycle is associated with bradyzoite differentiation in Toxoplasma gondii. , 2003, Molecular and biochemical parasitology.

[11]  Jessica C Kissinger,et al.  Gene discovery in the apicomplexa as revealed by EST sequencing and assembly of a comparative gene database. , 2003, Genome research.

[12]  D. Morgades,et al.  Cyst burden in the brains of Wistar rats fed Toxoplasma oocysts , 2003, Parasitology Research.

[13]  Zhijian J. Chen,et al.  Hijacking of Host Cell IKK Signalosomes by the Transforming Parasite Theileria , 2002, Science.

[14]  J. Boothroyd,et al.  Population biology of Toxoplasma gondii and its relevance to human infection: do different strains cause different disease? , 2002, Current opinion in microbiology.

[15]  B. Nare,et al.  Toxoplasma gondii Cyclic GMP-Dependent Kinase: Chemotherapeutic Targeting of an Essential Parasite Protein Kinase , 2002, Eukaryotic Cell.

[16]  J. Boothroyd,et al.  Toxoplasma gondii Asexual Development: Identification of Developmentally Regulated Genes and Distinct Patterns of Gene Expression , 2002, Eukaryotic Cell.

[17]  D. Roos,et al.  Identification and characterization of differentiation mutants in the protozoan parasite Toxoplasma gondii , 2002, Molecular microbiology.

[18]  J. Boothroyd,et al.  Genetic analysis of tachyzoite to bradyzoite differentiation mutants in Toxoplasma gondii reveals a hierarchy of gene induction , 2002, Molecular microbiology.

[19]  P. Liberator,et al.  Molecular characterization of a coccidian parasite cGMP dependent protein kinase. , 2002, Molecular and biochemical parasitology.

[20]  Myles Brown,et al.  Molecular Determinants for the Tissue Specificity of SERMs , 2002, Science.

[21]  B. Nare,et al.  Evaluation of a Cyclic GMP-Dependent Protein Kinase Inhibitor in Treatment of Murine Toxoplasmosis: Gamma Interferon Is Required for Efficacy , 2002, Antimicrobial Agents and Chemotherapy.

[22]  A. Mawson,et al.  SET-related Cell Division Autoantigen-1 (CDA1) Arrests Cell Growth* , 2001, The Journal of Biological Chemistry.

[23]  D. Roos,et al.  Defining the cell cycle for the tachyzoite stage of Toxoplasma gondii. , 2001, Molecular and biochemical parasitology.

[24]  U. Groß,et al.  Transcriptional profile of Toxoplasma gondii-infected human fibroblasts as revealed by gene-array hybridization , 2001, Molecular Genetics and Genomics.

[25]  I. D. Manger,et al.  Microarray Analysis Reveals Previously Unknown Changes in Toxoplasma gondii-infected Human Cells* , 2001, The Journal of Biological Chemistry.

[26]  Kami Kim,et al.  Cyclic Nucleotide Signaling in Toxoplasma gondii Bradyzoite Differentiation , 2001, Infection and Immunity.

[27]  L. Weiss,et al.  Toxoplasma gondii: from animals to humans. , 2000, International journal for parasitology.

[28]  W. Halford The essential prerequisites for quantitative RT-PCR , 1999, Nature Biotechnology.

[29]  M. Sendtner,et al.  Toxoplasma gondii in primary rat CNS cells: differential contribution of neurons, astrocytes, and microglial cells for the intracerebral development and stage differentiation. , 1999, Experimental parasitology.

[30]  J. K. Frenkel,et al.  Infection and immunity with the RH strain of Toxoplasma gondii in rats and mice. , 1999, The Journal of parasitology.

[31]  M. Maccoss,et al.  Potent, orally absorbed glucagon receptor antagonists. , 1999, Bioorganic & medicinal chemistry letters.

[32]  B. Gebhardt,et al.  The inherent quantitative capacity of the reverse transcription-polymerase chain reaction. , 1999, Analytical biochemistry.

[33]  D. Roos,et al.  Toxoplasma Gondii Bradyzoites Form Spontaneously during Sporozoite-Initiated Development , 1998, Infection and Immunity.

[34]  M. White,et al.  A cell cycle model for the tachyzoite of Toxoplasma gondii using the Herpes simplex virus thymidine kinase. , 1998, Molecular and biochemical parasitology.

[35]  D. Roos,et al.  Toxoplasma gondii sporozoites form a transient parasitophorous vacuole that is impermeable and contains only a subset of dense-granule proteins , 1997, Infection and immunity.

[36]  J. Dubey Bradyzoite‐Induced Murine Toxoplasmosis: Stage Conversion, Pathogenesis, and Tissue Cyst Formation in Mice Fed Bradvzoites of ‐ Different Strains of Toxoplasma gondii , 1997, The Journal of eukaryotic microbiology.

[37]  I. D. Manger,et al.  Genetic and biochemical analysis of development in Toxoplasma gondii. , 1997, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.

[38]  D. Roos,et al.  Stage-specific expression of a selectable marker in Toxoplasma gondii permits selective inhibition of either tachyzoites or bradyzoites. , 1997, Molecular and biochemical parasitology.

[39]  J. Dubey Distribution of tissue cysts in organs of rats fed Toxoplasma gondii oocysts. , 1997, The Journal of parasitology.

[40]  J. Dubey,et al.  Tissue cyst tropism in Toxoplasma gondii: a comparison of tissue cyst formation in organs of cats, and rodents fed oocysts , 1997, Parasitology.

[41]  C. Kahn,et al.  Insulin regulation of mitogen-activated protein kinase kinase (MEK), mitogen-activated protein kinase and casein kinase in the cell nucleus: a possible role in the regulation of gene expression. , 1997, The Biochemical journal.

[42]  F. Chiu,et al.  Growth and development of Toxoplasma gondii in human neurons and astrocytes. , 1996, Journal of neuropathology and experimental neurology.

[43]  J. Heesemann,et al.  Cloning and characterization of a bradyzoite‐specifically expressed gene (hsp30/bag1) of Toxoplasma gondii, related to genes encoding small heat‐shock proteins of plants , 1995, Molecular microbiology.

[44]  L. Weiss,et al.  A Cell Culture System for Study of the Development of Toxoplasma gondii Bradyzoites , 1995, The Journal of eukaryotic microbiology.

[45]  J. Dubremetz,et al.  Experimental induction of bradyzoite-specific antigen expression and cyst formation by the RH strain of Toxoplasma gondii in vitro. , 1994, Experimental parasitology.

[46]  J. Heesemann,et al.  Reduced replication of Toxoplasma gondii is necessary for induction of bradyzoite-specific antigens: a possible role for nitric oxide in triggering stage conversion , 1994, Infection and immunity.

[47]  J. Dubremetz,et al.  Toxoplasma gondii: kinetics of bradyzoite-tachyzoite interconversion in vitro. , 1993, Experimental parasitology.

[48]  L. David Sibley,et al.  Virulent strains of Toxoplasma gondii comprise a single clonal lineage , 1992, Nature.

[49]  J. Dubey Mouse pathogenicity of Toxoplasma gondii isolated from a goat. , 1980, American journal of veterinary research.

[50]  A. Nikolić,et al.  Stage conversion of Toxoplasma gondii RH parasites in mice by treatment with atovaquone and pyrrolidine dithiocarbamate. , 2005, Microbes and infection.

[51]  L. Kodjikian,et al.  Ocular manifestations in congenital toxoplasmosis , 2005, Graefe's Archive for Clinical and Experimental Ophthalmology.

[52]  Xiuyuan Hu,et al.  Relative gene-silencing efficiencies of small interfering RNAs targeting sense and antisense transcripts from the same genetic locus. , 2004, Nucleic acids research.

[53]  A. Capron,et al.  Infection with Toxoplasma gondii RH and Prugniaud strains in mice, rats and nude rats: kinetics of infection in blood and tissues related to pathology in acute and chronic infection. , 1999, Pathology, research and practice.